Balance, Fall Risk, and Gait in Women With Total Knee Arthroplasty

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age60-85
SponsorKarabuk University

About this trial

Total knee arthroplasty (TKA) is a commonly performed surgical procedure aimed at reducing pain, restoring joint function, and improving quality of life, particularly among older women. Despite improvements in pain and functional outcomes following TKA, findings regarding balance, fall risk, and gait performance remain inconsistent. Impairments in these parameters may adversely affect daily activities, independence, and overall quality of life.

Unlike previous studies that have primarily focused on one or two outcomes, this study will comprehensively evaluate balance, fall risk, gait performance, and quality of life in postmenopausal women who have undergone TKA. The findings are expected to provide a more holistic understanding of long-term functional outcomes following TKA and contribute to the planning of rehabilitation programs. Therefore, the aim of this study is to compare balance, fall risk, gait performance, and quality of life between postmenopausal women who have undergone TKA and healthy postmenopausal women.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Volunteering to participate in the study.

Being 60 years of age or older.

Having a Mini Mental Test score of 24 or higher.

Not having undergone previous arthroplasty surgery on the knee where surgery is planned.

Disqualifiers

Individuals whose vital signs are unstable after surgery, or who develop any major complications such as deep vein thrombosis, pulmonary embolism, wound infection, or prolonged anesthesia side effects.

Presence of any neurological, vestibular, visual, cardiopulmonary, auditory, or cognitive deficits that may affect measurements.

Individuals diagnosed with diabetes.

Trial population

Postmenopausal women who have and have not undergone total knee arthroplasty.

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

  • TKA group

    Other intervention

    having undergone TKA

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: control group1 intervention

Trial outcomes

Primary outcomes

1

Single Leg Standing Test

Single Leg Standing (SLJ) Test: Balance assessment will be performed using the single leg standing (SLJ) test. In the SLJ test, participants will be asked to stand with their extremities on the side that has not undergone surgery raised. The duration of the test in this position will be recorded. If the participant completes this position for 30 seconds, the test will be recorded as successful. Sarac et al. determined the validity and reliability of the SLJ test in TDA patients as an intraclass correlation coefficient \[ICC\]=0.74 (0.48-0.87).

Time frame
1 day
2

30-Second Sit-to-Stand Test

For the test, the individual sits in the middle of a chair without armrests, with a seat height of 43.18 cm, with their back straight, arms crossed over their chest, and feet flat on the floor. Upon the "Start" command, they rise from the chair without pushing off with their arms, stand upright, and then sit down again. Prior to the evaluation, the individual is assessed for two sit-to-stand repetitions to ensure they have learned the procedure. The number of correct standing repetitions within 30 seconds is recorded as the test value.

Time frame
1 day
3

Timed Up and Walk Test

The individual is asked to stand up from a chair, walk 3 meters at a safe and normal pace, turn around, walk back, and sit back down in the chair. The time is recorded in seconds. The test will be initiated with the patient's feet flat on the floor and their arms resting on the armrests of the chair. Three repetitions will be performed, and the best result will be recorded.

Time frame
1 day
4

10-Meter Walking Test

The 10-meter walking test will be used to assess walking ability. In this test, the individual will be asked to walk at their normal pace in a pre-measured 10-meter area (with or without walking aids). The timer will start when the individual's foot is on the starting line and end when they cross the finish line. Two measurements will be taken, and the best value will be recorded in meters per second (m/s).

Time frame
1 day

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: